Northwell Health

Neuvotion Secures over $1M in Seed Funding to Commercialize Neurostimulation Technology

Thursday, October 14, 2021 - 1:15pm

DARIEN, Conn., Oct. 14, 2021 /PRNewswire/ -- Neuvotion, Inc ., an early-stage medical device company developing neurostimulation products for the rehabilitation and physical therapy markets, today announced that it has received over $1M in seed funding.

Key Points: 
  • DARIEN, Conn., Oct. 14, 2021 /PRNewswire/ -- Neuvotion, Inc ., an early-stage medical device company developing neurostimulation products for the rehabilitation and physical therapy markets, today announced that it has received over $1M in seed funding.
  • This seed funding will be used by Neuvotion to expand its team, conduct a multi-site clinical study, and seek FDA clearance for its initial product.
  • Further, Neuvotion secured exclusive worldwide rights to transformative technology developed by its founder, Chad Bouton, who is a professor at the Feinstein Institutes for Medical Research at Northwell Health.
  • We feel strongly that this technology can help transform lives for people with spinal cord injuries, strokes and other neurological conditions."

Northwell Health Sends Global Health Team to Fight COVID in Barbados

Wednesday, October 13, 2021 - 7:43pm

A COVID-relief team from Northwell Health just returned from a seven-day medical mission to Barbados.

Key Points: 
  • A COVID-relief team from Northwell Health just returned from a seven-day medical mission to Barbados.
  • Northwell Healths Center for Global Health was mobilized after a chance meeting with the Barbadian Prime Minster, the Hon.
  • Northwell Health established the CGH in July 2019 with a vision to position Northwell Health as a global leader in healthcare and education.
  • Northwell Health is New York States largest health care provider and private employer, with 23 hospitals, 830 outpatient facilities and more than 16,600 affiliated physicians.

Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer

Wednesday, October 13, 2021 - 3:00pm

Longeviti Neuro Solutions , developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.

Key Points: 
  • Longeviti Neuro Solutions , developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.
  • View the full release here: https://www.businesswire.com/news/home/20211013005740/en/
    Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer (Photo: Business Wire)
    The core of Longevitis approach has always been guided by our desire to improve the patient experience, said Jesse Christopher, CEO and co-founder of Longeviti.
  • In addition to being an exceptional neurosurgeon, Dr. Langer is committed to innovation and bringing the highest quality technology to the operating room.
  • We are extremely fortunate to be guided by Dr. Langer as we bring our sonolucent products to patients across the country.

Feinstein Institutes names bioelectronic medicine lab the Tatyana and Alan Forman Family Laboratory of Biomedical Science

Wednesday, October 13, 2021 - 2:00pm

The bioelectronic medicine lab, run by Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, has been renamed the Tatyana and Alan Forman Family Laboratory of Biomedical Science.

Key Points: 
  • The bioelectronic medicine lab, run by Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, has been renamed the Tatyana and Alan Forman Family Laboratory of Biomedical Science.
  • View the full release here: https://www.businesswire.com/news/home/20211013005248/en/
    Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes lab is now called the Tatyana and Alan Forman Family Laboratory of Biomedical Science.
  • (Credit: Feinstein Institutes)
    Science, and particularly the exciting field of bioelectronic medicine, is the future of health care, said Mrs. Forman.
  • The Forman Family Lab at the Feinstein Institutes is committed to producing new knowledge to treat disease and alleviate suffering.

Brighton Health Plan Solutions to Administer Northwell Health's Employee Health Benefits Plan

Monday, October 11, 2021 - 5:47pm

NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Northwell Health , New York state's largest healthcare provider and private employer, has selected healthcare enablement company Brighton Health Plan Solutions to administer all of the employee health benefits plans for its approximately 75,000 employees and dependents who will be accessing care through the Northwell Direct network .

Key Points: 
  • NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Northwell Health , New York state's largest healthcare provider and private employer, has selected healthcare enablement company Brighton Health Plan Solutions to administer all of the employee health benefits plans for its approximately 75,000 employees and dependents who will be accessing care through the Northwell Direct network .
  • This is the first time Northwell Health has chosen direct contracting for its employee benefits plan.
  • Since 2021, Brighton has been administering Northwell Health's high-deductible health plan for approximately 1,000 non-unionized employees who transitioned to the Northwell Direct network.
  • Brighton Health Plan Solutions is an innovative healthcare enablement company based inNew York Cityon a mission to improve how healthcare is accessed and delivered in the self-funded health plan market.

Northwell Gives COVID-19 Booster Vaccine to Nurse Sandra Lindsay, Staff

Wednesday, October 6, 2021 - 8:34pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211006005964/en/
    Ms. Lindsay enthusiastically held high three fingers moments after Michelle Chester, DNP, director of Northwell Health Employee Health Services, administered the booster shot in front of reporters.
  • On Wednesday, Ms. Lindsay was back in front of cameras, one of five frontline health care workers who publicly received their booster shot.
  • And now, after this most difficult year, we are delighted to be able to offer our team members a booster shot of the Pfizer vaccine.
  • For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook , Twitter , Instagram and LinkedIn .

Nobel Laureate explains role of G-protein coupled receptors to treat disease in Feinstein Institutes’ Match Lecture

Wednesday, October 6, 2021 - 8:29pm

A pioneer in molecular pharmacology, Dr. Lefkowitz has dedicated more than five decades of research to discovering and understanding the function of GPCRs, particularly how to turn off – known as desensitization -- the receptors. These receptors are responsible for the senses of sweet and bitter taste and smell, among many other essential functions. Dr. Lefkowitz’s discoveries have had a significant clinical impact on the development of prescription drugs. More than a third of all prescription drug sales are of those that target the receptors, Dr. Lefkowitz and his team discovered.

Key Points: 
  • These receptors are responsible for the senses of sweet and bitter taste and smell, among many other essential functions.
  • More than a third of all prescription drug sales are of those that target the receptors, Dr. Lefkowitz and his team discovered.
  • The Match Lecture on October 5 was made possible by an endowment from the late Robert K. Match and his family and is held regularly by the Feinstein Institutes.
  • The Match Lecture invites Nobel Laureate scientists from around the world to speak to its faculty and staff.

MedCraft Healthcare Real Estate Completes the 150,000 Square Foot Maimonides Doctors Multispecialty Pavilion

Wednesday, October 6, 2021 - 4:30pm

MedCraft is one of the most active national healthcare real estate firms on the East Coast with a focus on development, acquisitions and real estate advisory with several leading providers and health systems.

Key Points: 
  • MedCraft is one of the most active national healthcare real estate firms on the East Coast with a focus on development, acquisitions and real estate advisory with several leading providers and health systems.
  • View the full release here: https://www.businesswire.com/news/home/20211006005752/en/
    MedCraft Healthcare Real Estate Principal Keith Beneke joins Maimonides President & CEO Kenneth Gibbs and a team of distinguished executives and departmental leaders to cut the ceremonial ribbon at the grand opening of the Maimonides Doctors Multispecialty Pavilion.
  • Maimonides Doctors Pavilion, the new flagship center of Maimonides system of care, represents a major milestone in the continued transformation of Maimonides to better serve patients.
  • About MedCraft Healthcare Real Estate, LLC
    MedCraft Healthcare Real Estate is a full-service healthcare real estate firm that specializes in advisory, development, and financing services to health systems and physicians.

Henry Schein’s Practice Pink Program Celebrates 15th Anniversary Supporting the Global Fight Against Cancer

Tuesday, October 5, 2021 - 11:30am

Henry Schein, Inc. (Nasdaq: HSIC) today announced the 15th anniversary of its Practice Pink program supporting nonprofit organizations dedicated to the fight against cancer.

Key Points: 
  • Henry Schein, Inc. (Nasdaq: HSIC) today announced the 15th anniversary of its Practice Pink program supporting nonprofit organizations dedicated to the fight against cancer.
  • Practice Pink is a global initiative of Henry Schein Cares, the Companys global corporate social responsibility program.
  • To date, Henry Schein has raised more than $1.7 million through Practice Pink.
  • Customers can obtain more information about these products in the Henry Schein Dental and Medical catalogs.

Investing in Future Scientists, Feinstein Institutes Gets $1.5M NIH Grant to Develop Training Program

Friday, October 1, 2021 - 3:38pm

The grant will support the development of a rigorous training program in translational immunology for two pre-doctoral and one post-doctoral candidates in the Institute of Molecular Medicine at the Feinstein Institutes.

Key Points: 
  • The grant will support the development of a rigorous training program in translational immunology for two pre-doctoral and one post-doctoral candidates in the Institute of Molecular Medicine at the Feinstein Institutes.
  • View the full release here: https://www.businesswire.com/news/home/20211001005517/en/
    Anne Davidson, MBBS, professor in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research.
  • Scientific advancements require training up-and-coming scientists, said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes.
  • The Feinstein Institutes continues to receive significant extramural funding, including a recent $1.3 million NIH grant to study neuro-immune signaling for bioelectronic medicine research and a $2.9 million NIH grant to investigate in-vitro fertilization genetic risk factors .